Wegovy HD is a higher-dose version of Wegovy that delivers 7.2 mg of semaglutide once weekly. The FDA approved it on March 19, 2026, for adults with obesity who need more weight loss than the standard 2.4 mg dose provides. In the STEP UP trial, patients on Wegovy HD lost an average of 20.7% of their body weight over 72 weeks — roughly six percentage points more than the standard dose. This guide explains who Wegovy HD is for, how it works, what it costs, and how to switch up from the 2.4 mg injection.
Key takeaways
- Wegovy HD is once-weekly semaglutide at 7.2 mg, three times the standard dose.
- The FDA approved Wegovy HD on March 19, 2026, under the Commissioner’s National Priority Voucher pilot.
- Wegovy HD is for adults who tolerated 2.4 mg for at least 4 weeks and still need more weight loss.
- In the STEP UP trial, Wegovy HD produced 20.7% mean weight loss over 72 weeks.
- About one in three patients lost 25% or more of their starting body weight.
- Side effects match Wegovy 2.4 mg, with higher rates of dysesthesia (tingling sensations).
- Wegovy HD self-pay price starts at $399/month, or as low as $25/month with commercial insurance.
- Novo Nordisk launched Wegovy HD in the US in April 2026.
What is Wegovy HD?
Wegovy HD is the brand name for once-weekly semaglutide injection at 7.2 mg. It is the highest FDA-approved dose of any GLP-1 medication for chronic weight management in adults. Novo Nordisk makes it, the same company behind Wegovy, Ozempic, and Rybelsus.
Wegovy HD contains the same active ingredient as standard Wegovy. It works the same way — by mimicking the natural GLP-1 hormone that reduces appetite and slows stomach emptying. The difference is the dose. At 7.2 mg, the medication produces stronger appetite suppression and more total weight loss for most patients.
Wegovy HD is delivered through a single-dose prefilled pen. Each pen contains one weekly dose. The injection goes under the skin in the abdomen, thigh, or upper arm — the same technique as the lower-dose Wegovy pens.
How is Wegovy HD different from standard Wegovy?
Both drugs are semaglutide injections, but they are not interchangeable. The dose, eligibility, and weight loss results differ. The table below shows the main differences.
| Feature | Wegovy (standard) | Wegovy HD |
|---|---|---|
| FDA approval | June 2021 | March 19, 2026 |
| Maintenance dose | 1.7 mg or 2.4 mg weekly | 7.2 mg weekly |
| Dosing frequency | Once weekly injection | Once weekly injection |
| Average weight loss | 14.9% (STEP 1, 68 weeks) | 20.7% (STEP UP, 72 weeks) |
| ≥25% weight loss | 17.0% of patients | 33.2% of patients |
| Self-pay price (2026) | ~$349/month | ~$399/month |
| Eligibility | Adults with obesity or overweight + comorbidity | Adults already tolerating 2.4 mg for ≥4 weeks |
Wegovy HD does not replace standard Wegovy. Most patients still start treatment at 0.25 mg and follow the same titration schedule. Wegovy HD is a maintenance option for patients who need more weight loss after reaching 2.4 mg.
Who is Wegovy HD for?
Wegovy HD is for adults with obesity (BMI 30 or higher) who need more weight reduction after the standard dose. The FDA label sets three eligibility rules:
- The patient must be 18 years or older.
- The patient must have tolerated Wegovy 2.4 mg weekly for at least 4 weeks.
- More weight reduction must be clinically indicated by the prescribing provider.
Some adults with overweight (BMI 27–29.9) and a weight-related condition also qualify, but they must meet the same tolerability rule. People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) cannot use Wegovy HD.
Patients who reach a good weight on 2.4 mg, or those who only need modest additional weight loss, usually do not need Wegovy HD. The decision rests with a healthcare provider who knows your history.
How much weight can you lose on Wegovy HD?
Adults on Wegovy HD lost an average of 20.7% of their body weight over 72 weeks in the STEP UP trial. About 33% of participants lost 25% or more — results previously seen only with bariatric surgery. Adults with type 2 diabetes lost an average of 14.1% in the parallel STEP UP T2D trial.
Figure 1. STEP UP trial milestones: Wegovy HD vs. Wegovy 2.4 mg vs. placebo at 72 weeks.
The STEP UP trial randomized 1,407 adults with obesity (BMI ≥30) and no diabetes. They were assigned to Wegovy HD 7.2 mg, Wegovy 2.4 mg, or placebo for 72 weeks. The table below shows how many patients reached each weight loss milestone.
| Weight loss milestone | Wegovy HD | Wegovy 2.4 mg | Placebo |
|---|---|---|---|
| ≥5% of body weight | 88.7% | 80.5% | 38.3% |
| ≥10% of body weight | 78.7% | 64.8% | 18.4% |
| ≥15% of body weight | 65.1% | 47.0% | 7.6% |
| ≥20% of body weight | 49.3% | 31.6% | 3.1% |
| ≥25% of body weight | 33.2% | 17.0% | 0.7% |
Waist size also dropped further on the higher dose. Patients on Wegovy HD reduced their waist by 11.7 cm on average, compared with 8.6 cm at 2.4 mg and 1.3 cm with placebo. This reflects fat loss around the organs — a strong marker for cardiometabolic health.
How do you take Wegovy HD?
Wegovy HD is injected once a week on the same day, with or without food. The single-dose pen makes the injection simple: uncap, place against the skin, press, and hold. The injection site can be the abdomen, thigh, or upper arm.
You do not start at 7.2 mg. You reach it through the standard Wegovy titration:
- 0.25 mg weekly for weeks 1–4.
- 0.5 mg weekly for weeks 5–8.
- 1.0 mg weekly for weeks 9–12.
- 1.7 mg weekly for weeks 13–16.
- 2.4 mg weekly for at least 4 weeks (weeks 17–20).
- 7.2 mg weekly from week 21 onward (Wegovy HD maintenance).
Most patients reach Wegovy HD around 4–5 months after starting treatment. If side effects appear during titration, your provider can hold you at a lower dose longer. Store Wegovy HD pens in the refrigerator at 36–46°F. Pens stay stable at room temperature for up to 28 days.
How to switch from Wegovy 2.4 mg to Wegovy HD
Switching to Wegovy HD is straightforward for patients already on the 2.4 mg dose. The transition follows three steps:
- Complete at least 4 weeks at 2.4 mg with stable tolerance.
- Discuss your weight loss progress with your prescribing provider.
- Replace the 2.4 mg pen with a 7.2 mg pen on your next scheduled injection day.
No washout period is needed. The injection day stays the same. Most patients see additional weight loss within 8–12 weeks after moving to the higher dose. If side effects flare, your provider may step you back down to 2.4 mg.
Wegovy HD side effects
Wegovy HD shares the same safety profile as standard Wegovy. The most common side effects are gastrointestinal and usually mild. They tend to peak after the dose increase to 7.2 mg and ease within 1–2 weeks.
The most reported side effects are:
- Nausea, vomiting, diarrhea, constipation.
- Stomach pain, bloating, belching.
- Decreased appetite, mild fatigue, headache.
- Dysesthesia — tingling, numbness, or altered skin sensation. About 22% of patients reported this on Wegovy HD.
Only 3.3% of STEP UP participants stopped treatment because of side effects. The trial also found no new safety signals at the higher dose. Wegovy HD carries the same boxed warning as the lower doses for thyroid C-cell tumors. See the full FDA Wegovy label for the complete safety profile.
How much does Wegovy HD cost in 2026?
Wegovy HD has a self-pay price of $399 per month through NovoCare Pharmacy. The list price is $1,349 per package, which most people do not pay directly. The actual out-of-pocket cost depends on insurance and savings programs.
Common Wegovy HD payment paths:
- With commercial insurance + savings offer: as little as $25/month, up to $100 in monthly savings.
- Self-pay through NovoCare: $399/month for Wegovy HD 7.2 mg.
- List price (rare): $1,349.02 per package without any discounts.
Government insurance (Medicare, Medicaid, VA, TRICARE) usually does not cover Wegovy HD for weight loss alone. Some plans cover it when prescribed for cardiovascular risk reduction. Novo Nordisk has announced a planned list price cut to $675/month starting January 1, 2027.
Wegovy HD vs Wegovy 2.4 mg vs Wegovy pill
Wegovy HD is one of four semaglutide-based options for weight loss. The table below compares it to the standard Wegovy injection, the new oral Wegovy pill, and Ozempic.
| Feature | Wegovy HD | Wegovy 2.4 mg | Wegovy pill | Ozempic |
|---|---|---|---|---|
| Form | Injection | Injection | Oral tablet | Injection |
| Maintenance | 7.2 mg weekly | 2.4 mg weekly | 25 mg daily | 2.0 mg weekly |
| Weight loss | 20.7% | 14.9% | 13.6–16.6% | Off-label use |
| FDA use | Weight loss | Weight loss | Weight loss | Type 2 diabetes |
| Self-pay (2026) | $399/mo | $349/mo | From $149/mo | $499/mo (typical) |
Wegovy HD delivers the most weight loss on paper. The Wegovy pill suits patients who avoid needles. Standard Wegovy 2.4 mg remains the right choice for most adults starting GLP-1 therapy. Ozempic is approved for diabetes only — not for weight loss.
Conclusion
Wegovy HD gives adults with obesity a stronger option when 2.4 mg stops producing results. The 7.2 mg dose adds about 5–6 percentage points of weight loss on average, and roughly doubles the chance of losing 25% or more of starting body weight. The trade-off is a slightly higher rate of side effects and a higher monthly cost.
Wegovy HD is not a first-line treatment. Patients reach it only after months of titration and at least 4 weeks of stable use at 2.4 mg. A licensed prescriber can confirm whether you meet the criteria. Schedule a free consultation with Heally to discuss the right semaglutide treatment plan for your weight goals.
FAQ
Is Wegovy HD the same as Wegovy?
Wegovy HD contains the same active ingredient as Wegovy — semaglutide. The difference is the dose. Standard Wegovy maintenance is 1.7 mg or 2.4 mg weekly. Wegovy HD maintenance is 7.2 mg weekly.
How much more weight can you lose on Wegovy HD?
Patients on Wegovy HD lost an average of 20.7% of body weight over 72 weeks, compared with 17.5% on Wegovy 2.4 mg. That is roughly 5–6 percentage points more, or about 13–15 extra pounds for a 220-pound adult.
Who can take Wegovy HD?
Adults with obesity (BMI ≥30) who have tolerated Wegovy 2.4 mg for at least 4 weeks and still need more weight loss. People with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome cannot take Wegovy HD.
Can you start treatment directly at Wegovy HD?
No. The FDA label requires at least 4 weeks at 2.4 mg before stepping up. Starting at 7.2 mg would cause severe nausea, vomiting, and dehydration. Standard titration takes about 4–5 months to reach the maintenance dose.
How much does Wegovy HD cost without insurance?
Wegovy HD self-pay price is $399/month through NovoCare Pharmacy. The list price is $1,349 per package. With commercial insurance and the Wegovy Savings Offer, eligible patients pay as little as $25/month.
Does Wegovy HD have more side effects than Wegovy 2.4 mg?
The side effects are similar, but rates are slightly higher on Wegovy HD. About 22% of patients reported dysesthesia (skin tingling) versus a lower rate on 2.4 mg. Only 3.3% of patients stopped Wegovy HD due to side effects.
How long does it take Wegovy HD to work?
Most patients lose weight starting in the first 4–8 weeks of standard Wegovy treatment. Stepping up to 7.2 mg usually adds further weight loss within 8–12 weeks. The full weight loss effect can take 12–18 months.
Can I switch from the Wegovy pill to Wegovy HD?
Yes, but only with a prescriber. Stop the pill first, then start the injection. The maintenance dose for Wegovy HD is reached only after at least 4 weeks at 2.4 mg. Do not skip the titration steps.
Sources
- Novo Nordisk — Wegovy HD (semaglutide 7.2 mg) FDA approval announcement, March 2026
- The Lancet Diabetes & Endocrinology — STEP UP trial: once-weekly semaglutide 7.2 mg in adults with obesity (2025)
- FDA — Wegovy (semaglutide) prescribing information, 2025
- PR Newswire — FDA approves Wegovy HD injection (Novo Nordisk press release)
- NovoCare — Wegovy cost and coverage information
- ClinicalTrials.gov — STEP UP trial protocol (NCT05646706)
- New England Journal of Medicine — STEP 1 trial: once-weekly semaglutide 2.4 mg
Medical disclaimer
This article is for informational purposes only and does not replace medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing a semaglutide prescription. Individual results vary.